US District Court Judge Mark Wolf dismissed patent claims filed by several biotechnology companies (including Genzyme Corp. and Biogen Idec Inc.) against Columbia University that alleged the New York school was improperly trying to extend its rights to a process widely used to engineer new drugs. Columbia had collected several hundred million dollars over the […]